doi: 10.3389/fnagi.2025.1601602 Received 28 March 2025 Accepted 03 July 2025 Published 24 July 2025 Volume 17 - 2025 Edited by Rita Machado De Olivera, New University of Lisbon, Portugal Reviewed by Venkateswarlu Kanamarlapudi, Swansea University Medical School, United Kingdom Joon W Shim, Marshall University, United States Updates Copyright 2025 Li, Huang, Wang, Huang, Shi, Luo and Huang
n = 172) or pioglitazone (45 mg daily
However, our armamentarium has another option with weight loss medications like Wegovy and Zepbound, also known as GLP-1 receptor agonists
Always consult your healthcare provider to determine if Semaglutide is right for you
[] The men treated with testosterone therapy displayed consistent improvement in libido and in 10 of the 12 sexual activity measurements , including frequency of intercourse, masturbation and nighttime erections